Artificial Intelligence in Medicine 2021
DOI: 10.1007/978-3-030-58080-3_252-1
|View full text |Cite
|
Sign up to set email alerts
|

AIM in Amyotrophic Lateral Sclerosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 25 publications
0
1
0
Order By: Relevance
“…ALS is considered rare, and, despite efforts to seek digital health solutions, there are still significant challenges to be tackled: these include the need for more data, studies, and evidence on disease incidence and prevalence, which are essential but scarce pieces of information in the context of global health [ 12 , 87 , 88 , 89 , 90 , 91 , 92 , 93 , 94 , 95 , 96 , 97 , 98 , 99 , 100 , 101 , 102 , 103 , 104 , 105 , 106 , 107 ]. There are few records or epidemiological studies in Brazil, and only two studies at national level have been mentioned in the scientific literature.…”
Section: Discussionmentioning
confidence: 99%
“…ALS is considered rare, and, despite efforts to seek digital health solutions, there are still significant challenges to be tackled: these include the need for more data, studies, and evidence on disease incidence and prevalence, which are essential but scarce pieces of information in the context of global health [ 12 , 87 , 88 , 89 , 90 , 91 , 92 , 93 , 94 , 95 , 96 , 97 , 98 , 99 , 100 , 101 , 102 , 103 , 104 , 105 , 106 , 107 ]. There are few records or epidemiological studies in Brazil, and only two studies at national level have been mentioned in the scientific literature.…”
Section: Discussionmentioning
confidence: 99%